{"id":"NCT02510261","sponsor":"Alnylam Pharmaceuticals","briefTitle":"The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Participants Who Have Already Been Treated With ALN-TTR02 (Patisiran)","officialTitle":"A Multicenter, Open-Label, Extension Study to Evaluate the Long-term Safety and Efficacy of Patisiran in Patients With Familial Amyloidotic Polyneuropathy Who Have Completed a Prior Patisiran Clinical Study","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-07-16","primaryCompletion":"2022-11-23","completion":"2022-11-23","firstPosted":"2015-07-29","resultsPosted":"2023-12-06","lastUpdate":"2023-12-06"},"enrollment":211,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Amyloidosis"],"interventions":[{"type":"DRUG","name":"Patisiran","otherNames":["ALN-TTR02"]}],"arms":[{"label":"Prior Placebo Group of Study 004","type":"EXPERIMENTAL"},{"label":"Prior Patisiran Group of Study 004","type":"EXPERIMENTAL"},{"label":"Prior Patisiran Group of Study 003","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the safety and efficacy of long-term dosing with ALN-TTR02 (patisiran) in participants with transthyretin (TTR) mediated amyloidosis (ATTR).","primaryOutcome":{"measure":"Percentage of Participants With Adverse Events (AEs) Leading to Study Discontinuation","timeFrame":"First dose up to 28 days after last dose of study drug (approximately 5.6 years)","effectByArm":[{"arm":"Prior Placebo Group of Study 004","deltaMin":49,"sd":null},{"arm":"Prior Patisiran Group of Study 004","deltaMin":16.8,"sd":null},{"arm":"Prior Patisiran Group of Study 003","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":1},"locations":{"siteCount":56,"countries":["United States","Argentina","Australia","Brazil","Bulgaria","Canada","Cyprus","France","Germany","Italy","Japan","Malaysia","Mexico","Netherlands","Portugal","South Korea","Spain","Sweden","Taiwan","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["39804640","38548524","33212063"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":39,"n":49},"commonTop":["Diarrhoea","Oedema Peripheral","Urinary Tract Infection","Fall","Nasopharyngitis"]}}